JIANYANG WANG
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Radiotherapy Plus Anlotinib in LA-NSCLC Intolerable to cCRT (NCT07037680) | JIANYANG WANG | 2024-01-01 |
| The Effect of Prophylactic TPO Combined with BMS-IMRT to Esophageal Cancer Patients (NCT05944809) | JIANYANG WANG | 2023-07-20 |
Track JIANYANG WANG automatically
Every clearance here is in the API, with alerts when new ones post.